InvestorsObserver is giving ProQR Therapeutics NV (PRQR) an Analyst Rating Rank of 17, meaning PRQR is ranked higher by analysts than 17% of stocks. The average price target for PRQR is $1.4 and analyst’s rate the stock as a Buy.
Wall Street analysts are rating PRQR a Buy today. Find out what this means to you and get the rest of the rankings on PRQR!
Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported.
InvestorsObserver takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.
What's Happening With ProQR Therapeutics NV Stock Today?
ProQR Therapeutics NV (PRQR) stock is trading at $1.30 as of 12:12 PM on Monday, Nov 28, a drop of -$0.04, or -2.99% from the previous closing price of $1.34. The stock has traded between $1.28 and $1.35 so far today. Volume today is low. So far 250,403 shares have traded compared to average volume of 952,408 shares.
Click Here to get the full Stock Report for ProQR Therapeutics NV stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
